Quiero saber acerca de...

Federal Register / Vol. 86, No. 134 / Friday, July 16, 2021 / Proposed Rules Signed in Washington, DC, on July 9, 2021.
Treena V. Garrett, Federal Register Liaison Officer, U.S.
Department of Energy.
FR Doc. 202114977 Filed 71521; 8:45 am BILLING CODE 645001P

DEPARTMENT OF JUSTICE
Drug Enforcement Administration 21 CFR Part 1308
Docket No. DEA495

Schedules of Controlled Substances:
Placement of N-Ethylhexedrone, alphaPyrrolidinohexanophenone, 4-Methylalpha-ethylaminopentiophenone, 4Methyl-alphapyrrolidinohexiophenone, alphaPyrrolidinoheptaphenone, and 4Chloro-alphapyrrolidinovalerophenone in Schedule I
Drug Enforcement Administration, Department of Justice.
ACTION: Notice of proposed rulemaking.
AGENCY:

The Drug Enforcement Administration proposes placing six synthetic cathinones, as identified in this proposed rule, in schedule I of the Controlled Substances Act. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I
controlled substances on persons who handle manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess, or propose to handle these six specified controlled substances.
DATES: Comments must be submitted electronically or postmarked on or before August 16, 2021.
Requests for hearing and waivers of an opportunity for a hearing or to participate in a hearing must be received on or before August 16, 2021.
ADDRESSES: To ensure proper handling of comments, please reference Docket No. DEA495 on all electronic and written correspondence, including any attachments.
Electronic comments: The Drug Enforcement Administration DEA
encourages that all comments be submitted electronically through the Federal eRulemaking Portal which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to http
www.regulations.gov and follow the
jbell on DSKJLSW7X2PROD with PROPOSALS

SUMMARY:

VerDate Sep<11>2014

16:52 Jul 15, 2021

Jkt 253001

online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.
Paper comments: Paper comments that duplicate the electronic submission are not necessary. Should you wish to mail a paper comment, in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attn: DEA
Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
Hearing requests: All requests for a hearing and waivers of participation, together with a written statement of position on the matters of fact and law asserted in the hearing, must be sent to:
Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing and waivers of participation should also be sent to: 1 Drug Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and 2 Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
FOR FURTHER INFORMATION CONTACT:
Terrence L. Boos, Ph.D., Drug and Chemical Evaluation Section, Drug Enforcement Administration;
Telephone: 571 3623249.
SUPPLEMENTARY INFORMATION:
In this proposed rule, the Drug Enforcement Administration DEA
proposes to permanently schedule the following six controlled substances in schedule I of the Controlled Substances Act CSA, including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
N-ethylhexedrone other names: aethylaminohexanophenone, ethyl hexedrone, HEXEN, 2-ethylamino-1phenylhexan-1-one, alpha-pyrrolidinohexanophenone other names: a-pyrrolidinohexanophenone, alpha-PHP, a-PHP, PV7, 1-phenyl-2-pyrrolidin-1-ylhexan1-one, 4-methyl-alphaethylaminopentiophenone other names:
N-ethyl-4-methylnorpentedrone, 4methyl-a-ethylaminopentiophenone, 4-

PO 00000

Frm 00033

Fmt 4702

Sfmt 4702

37719

MEAP, 2-ethylamino-1-4methylphenylpentan-1-one, 4-methyl-alphapyrrolidinohexiophenone other names:
4-methyl-a-PHP, 4-methyl PHP, PV4, 4-MPHP, MPHP, 4-methyl-alphapyrrolidino hexanophenone, 1-4methylphenyl-2-pyrrolidin-1-ylhexan1-one, alpha-pyrrolidinoheptaphenone other names: alphapyrrolidinoheptiophenone, alpha-PHpP, PV8, 1-phenyl-2-pyrrolidin-1ylheptan-1-one, and 4-chloro-alphapyrrolidinovalerophenone other names:
4-chloro-a-pyrrolidinopentiophenone, 4-chloro-a-PVP, 4-Cl-a-PVP, 4-chloro-21-pyrrolidinyl-valerophenone, 1-4chlorophenyl-2-pyrrolidin-1ylpentan-1-one.
Posting of Public Comments Please note that all comments received in response to this docket are considered part of the public record.
They will, unless reasonable cause is given, be made available by DEA for public inspection online at http
www.regulations.gov. Such information includes personal identifying information such as your name, address, etc. voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received. If you want to submit personal identifying information such as your name, address, etc. as part of your comment, but do not want it to be made publicly available, you must include the phrase PERSONAL IDENTIFYING
INFORMATION in the first paragraph of your comment. You must also place all of the personal identifying information you do not want made publicly available in the first paragraph of your comment and identify what information you want redacted.
If you want to submit confidential business information as part of your comment, but do not want it to be made publicly available, you must include the phrase CONFIDENTIAL BUSINESS
INFORMATION in the first paragraph of your comment. You must also prominently identify the confidential business information to be redacted within the comment.
Comments containing personal identifying information or confidential business information identified as directed above will be made publicly available in redacted form. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be made publicly available.
Comments posted to http
www.regulations.gov may include any
E:FRFM16JYP1.SGM

16JYP1